COVID-19 monitoring in workers at a Brazilian public university: a retrospective cohort study

Autores/as

DOI:

https://doi.org/10.11606/issn.2176-7262.rmrp.2023.208895

Palabras clave:

Epidemiology, COVID-19, SARS-CoV-2, Primary health care

Resumen

Introduction: primary care action strategies are relevant for disease prevention and health promotion, as well as for the initial management of suspected cases and the individual monitoring of patients with confirmed diagnoses of COVID-19. This study aimed to evaluate the outcome of clinical worsening and demographic, occupational, and
clinical variables of workers with COVID-19 in a community health center at a public university in southeastern Brazil. Methods: a retrospective cohort study was conducted with 1,459 symptomatic workers with COVID-19. Data were extracted from the database of the unit’s epidemiological surveillance center between March 2020 and March 2021. Results: The average age of participants was 41.1 (SD 10.8) years, most women (71.1%), who had
obesity (19.9%) and hypertension (17.0%). Among the symptoms, headache (75.3%) and cough (74.9%) stood out. The worsening of clinical outcome during follow-up occurred in 3.4% of cases. The demographic, occupational and clinical factors associated with clinical worsening were gender, professional category, hypertension, diabetes
mellitus, obesity, dyslipidemia, olfactory disorders, cough, fever, and dyspnea. The Poisson regression showed that the prevalence of clinical worsening was greater with age, obesity, fever, and dyspnea. Conclusion: Clinical worsening occurred in 3.4% of the cases and was more prevalent according to age, obesity, fever, and dyspnea. The follow-up has shown promise in the early detection and treatment of COVID-19.

Descargas

Los datos de descarga aún no están disponibles.

Biografía del autor/a

  • Leila Tassia Pagamicce, Universidade Estadual de Campinas. Faculdade de Enfermagem, Campinas, (SP), Brazil

    RN, MSc’student

  • Carla Renata Silva Andrechuk, Universidade Estadual de Campinas. Faculdade de Enfermagem, Campinas, (SP), Brazil

    RN, PhD

  • Mariane Karin de Moraes Oliveira , Universidade Estadual de Campinas. Faculdade de Enfermagem, Campinas, (SP), Brazil

    RN, MSc

  • Edite Kazue Taninaga , Universidade Estadual de Campinas. Centro de Saúde da Comunidade, Campinas, (SP), Brazil

    RN

  • Inajara de Cassia Guerreiro , Universidade Estadual de Campinas. Centro de Saúde da Comunidade, Campinas, (SP), Brazil

    RN

  • Maria Helena Postal Pavan , Universidade Estadual de Campinas. Centro de Saúde da Comunidade, Campinas, (SP), Brazil

    M.D

  • Rose Clélia Grion Trevisane , Universidade Estadual de Campinas. Centro de Saúde da Comunidade, Campinas, (SP), Brazil

    RN

  • Roberta Cunha Matheus Rodrigues , Universidade Estadual de Campinas. Faculdade de Enfermagem, Campinas, (SP), Brazil

    RN, PhD 

Referencias

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 2020; 324(8):782–93. https://doi.org/10.1001/jama.2020.12839

World Health Organization. Coronavirus disease (COVID-19) pandemic. WHO Coronavirus (COVID-19) Dashboard (2023a). Available at: https://covid19.who.int/

Burki T. COVID-19 in Latin America. Lancet Infect Dis 2020; 20(5):547-48. https://doi.org/10.1016/S1473-3099(20)30303-0

Brasil. Ministério da Saúde. Painel Coronavírus 2023. Available at: https://covid.saude.gov.br/ (Original work published in Portuguese).

Li J, Huang DQ, Zou B, Yang H, Hui WZ, Rui F, et al. Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol 2021; 93(3): 1449–58. https://doi.org/10.1002/jmv.26424

Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 2021;19(3):141–54. https://doi.org/10.1038/s41579-020-00459-7

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323(13):1239-42. https://doi.org/10.1001/jama.2020.2648

Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. The Am J Emerg Med 2020; 38(7):1504–7. https://doi.org/10.1016/j.ajem.2020.04.048

Aghagoli G, Gallo Marin B, Soliman LB, Sellke F W. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. J Card Surg 2020; 35(6):1302–5. https://doi.org/10.1111/jocs.14538

Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397 (10270): 220-32. https://doi.org/10.1016/S0140-6736(20)32656-8

Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ 2020; 370: m3026. https://doi.org/10.1136/bmj.m3026

BRASIL. Ministério da Saúde. Secretaria de Atenção Primária à Saúde. Protocolo de Manejo Clínico do Coronavírus (COVID-19) na Atenção Primária à Saúde, versão 7. Brasília – DF, Abril de 2020. Available at: https://saude.rs.gov.br/upload/arquivos/202004/14140606-4-ms-protocolomanejo-aps-ver07abril.pdf (Original work published in Portuguese).

Pagano M, Gauvreau K. Principles of Bioestatistics, Ed. Thomson, São Paulo, 2004.

Mehta C, Patel N. A network algorithm for performing Fisher's exact test in r × c contingency tables. J Am Stat Assoc 1983; 78(382):427-34. https://doi.org//10.2307/2288652

Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159(7):702-6. https://doi.org/10.1093/aje/kwh090

Rodríguez-Molinero A, Gálvez-Barrón C, Miñarro A, Macho O, López GF, Robles MT, et al, Association between COVID-19 prognosis and disease presentation, comorbidities and chronic treatment of hospitalized patients. PloS one 2020;15(10): e0239571. https://doi.org/10.1371/journal.pone.0239571

Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nature medicine, 27(1), 28–33. https://doi.org/10.1038/s41591-020-01202-8

Buonafine CP, Paiatto B, Leal FB, de Matos SF, de Morais CO, Guerra GG, et al. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil. BMC Infect Dis 2020; 20(1): 917. https://doi.org/10.1186/s12879-020-05662-8

Gómez-Ochoa SA, Franco OH, Rojas LZ, Raguindin PF, Roa-Díaz ZM, Wyssmann BM, et al. COVID-19 in health-care workers: a living systematic review and meta-Analysis of prevalence, risk factors, clinical characteristics, and outcomes. Am J Epidemiol 2021;190(1): 161–75. https://doi.org/10.1093/aje/kwaa191

World Health Organization. Noncommunicable diseases progress monitor 2020. Geneva: WHO; 2020. Available at: https://www.who.int/publications-detail/ncd-progress-monitor-2020

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, the Northwell COVID-19 Research Consortium, Barnaby DP, Becker LB, Chelico, JD, Cohen SL, Cookingham J, Coppa K, Diefenbach MA, Dominello AJ, Duer-Hefele J, Falzon L, Gitlin J, Hajizadeh N, Harvin TG, Zanos TP. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA 2020; 323(20):2052-9. https://doi.org/10.1001/jama.2020.6775

Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 Pandemic. JACC 2020; 75(18): 2352–71. https://doi.org/10.1016/j.jacc.2020.03.031

Burn E, Tebé C, Fernandez-Bertolin S, Aragon M, Recalde M, Roel E, et al. The natural history of symptomatic COVID-19 during the first wave in Catalonia. Nat Commun 2021; 12(1): 777. https://doi.org/10.1038/s41467-021-21100-y

Chen Y, Klein SL, Garibaldi BT, Li H, Wu C, Osevala NM, et al. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res Rev 2021; 65:101205. https://doi.org/10.1016/j.arr.2020.101205

Finer N, Garnett SP, Bruun JM. COVID-19 and obesity. Clin Obes 2020; 10(3): e12365. https://doi.org/10.1111/cob.12365

Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, Alsukait RF, Alluhidan M, Alazemi N, Shekar M. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes Rev, 2020; 21(11): e13128. https://doi.org/10.1111/obr.13128

World Health Organization. Coronavirus disease (COVID-19) pandemic. Geneva: WHO; 2019 Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019

Shi Y, Wang G, Cai XP, Deng JW, Zheng L, Zhu HH, Zheng M, Yang B, Chen Z. An overview of COVID-19. J Zhejiang Univ Sci B. 2020;21(5):343-60. https://doi.org/10.1631/jzus.B2000083

Blazey-Martin D, Barnhart E, Jr JG, Vazquez GA. Primary care population management for COVID-19 Patients. J Gen Intern Med 2020; 35(10):3077–80. https://doi.org/10.1007/s11606-020-05981-1

Sohrabi MR, Amin R, Maher A, Bahadorimonfared A, Janbazi S, Hannani K, et al. Sociodemographic determinants and clinical risk factors associated with COVID-19 severity: a cross-sectional analysis of over 200,000 patients in Tehran, Iran. BMC Infect Dis 2021; 21(1): 474. https://doi.org/10.1186/s12879-021-06179-4

Descargas

Publicado

— Actualizado el 2023-12-18

Número

Sección

Artigo Original

Cómo citar

1.
Pagamicce LT, Andrechuk CRS, Oliveira MK de M, Taninaga EK, Guerreiro I de C, Pavan MHP, et al. COVID-19 monitoring in workers at a Brazilian public university: a retrospective cohort study. Medicina (Ribeirão Preto) [Internet]. 2023 Dec. 18 [cited 2024 May 15];56(4):e-208895. Available from: https://www.journals.usp.br/rmrp/article/view/208895